228 related articles for article (PubMed ID: 25250118)
1. Virotherapy in cancer.
Motalleb G
Iran J Cancer Prev; 2013; 6(2):101-7. PubMed ID: 25250118
[TBL] [Abstract][Full Text] [Related]
2. Novel Oncolytic Herpes Simplex Virus 1 VC2 Promotes Long-Lasting, Systemic Anti-melanoma Tumor Immune Responses and Increased Survival in an Immunocompetent B16F10-Derived Mouse Melanoma Model.
Uche IK; Fowlkes N; Vu L; Watanabe T; Carossino M; Nabi R; Del Piero F; Rudd JS; Kousoulas KG; Rider PJF
J Virol; 2021 Jan; 95(3):. PubMed ID: 33177208
[TBL] [Abstract][Full Text] [Related]
3. Oncolytic adenoviruses for cancer gene therapy.
Liu TC; Thorne SH; Kirn DH
Methods Mol Biol; 2008; 433():243-58. PubMed ID: 18679628
[TBL] [Abstract][Full Text] [Related]
4. Development of oncolytic viruses for cancer therapy.
Abd-Aziz N; Poh CL
Transl Res; 2021 Nov; 237():98-123. PubMed ID: 33905949
[TBL] [Abstract][Full Text] [Related]
5. Stem Cell-Based Cell Carrier for Targeted Oncolytic Virotherapy: Translational Opportunity and Open Questions.
Kim J; Hall RR; Lesniak MS; Ahmed AU
Viruses; 2015 Nov; 7(12):6200-17. PubMed ID: 26633462
[TBL] [Abstract][Full Text] [Related]
6. Targeting pediatric cancer stem cells with oncolytic virotherapy.
Friedman GK; Cassady KA; Beierle EA; Markert JM; Gillespie GY
Pediatr Res; 2012 Apr; 71(4 Pt 2):500-10. PubMed ID: 22430386
[TBL] [Abstract][Full Text] [Related]
7. Oncolytic virotherapy as promising immunotherapy against cancer: mechanisms of resistance to oncolytic viruses.
Goradel NH; Alizadeh A; Hosseinzadeh S; Taghipour M; Ghesmati Z; Arashkia A; Negahdari B
Future Oncol; 2022 Jan; 18(2):245-259. PubMed ID: 34821517
[TBL] [Abstract][Full Text] [Related]
8. Lung cancer and oncolytic virotherapy--enemy's enemy.
Li Z; Feiyue Z; Gaofeng L; Haifeng L
Transl Oncol; 2023 Jan; 27():101563. PubMed ID: 36244134
[TBL] [Abstract][Full Text] [Related]
9. Advanced new strategies for metastatic cancer treatment by therapeutic stem cells and oncolytic virotherapy.
Park GT; Choi KC
Oncotarget; 2016 Sep; 7(36):58684-58695. PubMed ID: 27494901
[TBL] [Abstract][Full Text] [Related]
10. Oncolytic Virotherapy.
Fatima M; Amraiz D; Navid MT
Cancer Treat Res; 2023; 185():105-126. PubMed ID: 37306907
[TBL] [Abstract][Full Text] [Related]
11. Co-delivery of novel bispecific and trispecific engagers by an amplicon vector augments the therapeutic effect of an HSV-based oncolytic virotherapy.
Ravirala D; Mistretta B; Gunaratne PH; Pei G; Zhao Z; Zhang X
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34230110
[TBL] [Abstract][Full Text] [Related]
12. Establishing a New Platform to Investigate the Efficacy of Oncolytic Virotherapy in a Human Ex Vivo Peritoneal Carcinomatosis Model.
Koch J; Beil J; Berchtold S; Mönch D; Maaß A; Smirnow I; Schenk A; Carter ME; Kloker LD; Leibold T; Renner P; Dahlke MH; Lauer UM
Viruses; 2023 Jan; 15(2):. PubMed ID: 36851574
[TBL] [Abstract][Full Text] [Related]
13. Virus, Oncolytic Virus and Human Prostate Cancer.
Liu GB; Zhao L; Zhang L; Zhao KN
Curr Cancer Drug Targets; 2017; 17(6):522-533. PubMed ID: 27993115
[TBL] [Abstract][Full Text] [Related]
14. Kinase inhibitors with viral oncolysis: Unmasking pharmacoviral approaches for cancer therapy.
Gilchrist VH; Jémus-Gonzalez E; Said A; Alain T
Cytokine Growth Factor Rev; 2020 Dec; 56():83-93. PubMed ID: 32690442
[TBL] [Abstract][Full Text] [Related]
15. Novel oncolytic viral therapies in patients with thoracic malignancies.
Ahmad Z; Kratzke RA
Oncolytic Virother; 2017; 6():1-9. PubMed ID: 28053943
[TBL] [Abstract][Full Text] [Related]
16. Promising oncolytic agents for metastatic breast cancer treatment.
Cody JJ; Hurst DR
Oncolytic Virother; 2015; 4():63-73. PubMed ID: 27512671
[TBL] [Abstract][Full Text] [Related]
17. Oncolytic Virotherapy by HSV.
Watanabe D; Goshima F
Adv Exp Med Biol; 2018; 1045():63-84. PubMed ID: 29896663
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potency of oncolytic virotherapy in breast cancer targeting, current status and perspective.
Ebrahimi S; Ghorbani E; Shafiee M; Ryzhikov M; Hassanian SM; Azadmanesh K
J Cell Biochem; 2019 Mar; 120(3):2801-2809. PubMed ID: 30260014
[TBL] [Abstract][Full Text] [Related]
19. Poxvirus oncolytic virotherapy.
Torres-Domínguez LE; McFadden G
Expert Opin Biol Ther; 2019 Jun; 19(6):561-573. PubMed ID: 30919708
[TBL] [Abstract][Full Text] [Related]
20. Virus combinations and chemotherapy for the treatment of human cancers.
Kumar S; Gao L; Yeagy B; Reid T
Curr Opin Mol Ther; 2008 Aug; 10(4):371-9. PubMed ID: 18683102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
